Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Seattle Genetics Submits Supplemental BLA for Adcetris in T-Cell Lymphomas
Seattle Genetics Submits Supplemental BLA for Adcetris in T-Cell Lymphomas
Seattle Genetics Submits Supplemental BLA for Adcetris in T-Cell Lymphomas
Submitted by
admin
on November 5, 2018 - 11:19am
Source:
CP Wire
News Tags:
Seattle Genetics
Adcetris
T-cell lymphoma
Headline:
Seattle Genetics Submits Supplemental BLA for Adcetris in T-Cell Lymphomas
snippet:
PTCL accounts for approximately 10 percent of non-Hodgkin lymphoma cases in the U.S. and Europe
It may account for as much as 24 percent in parts of Asia.
Do Not Allow Advertisers to Use My Personal information
